A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2001
10/23/2001	US6306849 Selected derivatives of K-252a
10/23/2001	US6306453 Anti-stress agents for aquatic animals
10/23/2001	US6306438 For therapy of pain; storgae stability
10/23/2001	US6306425 Time release agents; therapy of drug abuse and drug dependence
10/23/2001	US6306423 Biocompatible implant for continuous in vivo release of a neurotoxin over a treatment period extending from one month to five years
10/23/2001	US6306403 Intracranial administration of botulinum toxin into a globus palladius or into ventrolateral thalamus, thereby reducing a dyskinesia of parkinson's disease
10/23/2001	US6306398 Delipidating plant powder by extraction of powder with a solution containing organic solvent; separating powder from organic solvent; extracting delipidated powder with solvent or phosphate buffered saline; separation to obtain retentate
10/23/2001	US6306392 Prevention and/or treatment of alterations of those organs which perform metabolic function, such as liver, kidneys, cardiovascular system and brain; for therapy of hepatosis, nephropathies and cardiovascular or cerebral damage damage
10/23/2001	CA2236368C Sublingual and buccal administration of selegiline
10/23/2001	CA2211284C Multiple unit sustained release dosage form
10/23/2001	CA2203310C Compressed matrix for slow release of salt of tianeptine sodium following oral administration
10/23/2001	CA2079342C Multi-functional pharmaceutical compounds and methods of use
10/23/2001	CA2049368C Treatment of cerebro-vascular disorders
10/23/2001	CA2047496C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
10/23/2001	CA2035397C Hexahydropyrrolo¬2,3-b\|indole carbamates, -ureas, -amides and related compounds, a process for their preparation and their use as medicaments
10/18/2001	WO2001077687A2 Prion-binding peptidic ligands and methods of using same
10/18/2001	WO2001077681A1 Tpst-assay for diagnosis of autism and related disorders
10/18/2001	WO2001077339A1 Human pyruvate dehydrogenese phosphatase
10/18/2001	WO2001077338A2 Human protein kinases and protein kinase-like enzymes
10/18/2001	WO2001077335A2 Listeria monocytogenes genome, polypeptides and uses
10/18/2001	WO2001077330A2 G protein-coupled receptors
10/18/2001	WO2001077327A1 THE HIGH BONE MASS GENE OF 11q13.3
10/18/2001	WO2001077326A1 Novel g protein-coupled receptor protein and dna thereof
10/18/2001	WO2001077325A1 Novel g protein-coupled receptor protein and dna thereof
10/18/2001	WO2001077322A1 Cryptic-like secreted protein
10/18/2001	WO2001077175A2 G protein-coupled receptors
10/18/2001	WO2001077174A2 Human transporters and ion channels
10/18/2001	WO2001077170A2 Multiprotein-complexes comprising a nmda receptor and uses thereof
10/18/2001	WO2001077169A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/18/2001	WO2001077167A2 Methods of investigating, diagnosing, and treating amyloidosis
10/18/2001	WO2001077166A1 Novel physiologically active peptides and use thereof
10/18/2001	WO2001077149A2 Regulation of human cyslt2-like gpcr protein
10/18/2001	WO2001077147A2 New bromodomain protein
10/18/2001	WO2001077139A1 8ss-HYDROCARBYL-SUBSTITUTED ESTRATRIENES FOR USE AS SELECTIVE ESTROGENS
10/18/2001	WO2001077138A1 8β-SUBSTITUTED-11β-PENTYL- AND 11β-HEXYL-ESTRA-1,3,5(10)-TRIENE DERIVATIVES
10/18/2001	WO2001077137A1 Albumin fusion proteins
10/18/2001	WO2001077111A1 Pyrazolo-triazine derivatives as ligands for gaba receptors
10/18/2001	WO2001077110A1 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
10/18/2001	WO2001077108A1 Therapeutically useful new salts of cck inhibitors, process for the preparation thereof and pharmaceutical preparations containing them
10/18/2001	WO2001077101A1 Chemical compounds
10/18/2001	WO2001077100A2 Benzoamide piperidine compounds as substance p antagonists
10/18/2001	WO2001077093A1 Estrogen agonist/antagonist metabolites
10/18/2001	WO2001077089A1 New neurokinin antagonists for use as medicaments
10/18/2001	WO2001077087A1 Novel compounds
10/18/2001	WO2001077086A1 SUBSTITUTED LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION
10/18/2001	WO2001077078A1 Novel pyridones and their use as modulators of serine hydrolase enzymes
10/18/2001	WO2001077074A1 Process for preparing optically active aminopentane derivatives
10/18/2001	WO2001077069A1 Naphthamide neurokinin antagonists for use as medicaments
10/18/2001	WO2001076629A1 Soluble beta amyloid precursor protein secretion promoters
10/18/2001	WO2001076614A1 Remedies
10/18/2001	WO2001076602A1 Apomorphine derivatives and methods for their use
10/18/2001	WO2001076596A1 Medicine for treating traumatic brain injury and other neuronal disorders
10/18/2001	WO2001076584A2 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases
10/18/2001	WO2001076580A1 Remedies
10/18/2001	WO2001076576A2 A pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
10/18/2001	WO2001076572A2 Use of compatible solutes as substances having free radical scavenging properties
10/18/2001	WO2001076571A2 Use of sabcomeline in the treatment of anxiety
10/18/2001	WO2001076568A2 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
10/18/2001	WO2001076530A2 Il-8 receptor antagonists
10/18/2001	WO2001063293A8 Diagnosis and treatment of schizophrenia
10/18/2001	WO2001038316A3 Sulfonyl oxazole amines and their use as 5-ht6 receptor ligands
10/18/2001	WO2001036626A3 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds
10/18/2001	WO2001023388A3 AMINO SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES
10/18/2001	WO2001020336A3 SCREENING FOR α2δ-1 SUBUNIT BINDING LIGANDS
10/18/2001	WO2001020004A3 Protein phosphatase and kinase proteins
10/18/2001	WO2000071518A3 Heterocyclic analgesic compounds and their use
10/18/2001	US20010032339 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1
10/18/2001	US20010031801 Pumping active agent, polymer, and solvent, form emulsion; forming an emulsion; solvent extraction;
10/18/2001	US20010031789 2-n-propyl-4-hexynoic acid; reduced adverse effects including neurotoxicity and teratogenic potential compared to valproic acid
10/18/2001	US20010031784 Antidepressants; simplification
10/18/2001	US20010031782 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
10/18/2001	US20010031777 Heterocyclic compounds and their therapeutic use
10/18/2001	US20010031767 Used as antidepressants, to treat obsessive compulsive disorder, panic disorders, bulimia, anorexia, pain, obesity, senile demential, migraines, and social phobias
10/18/2001	US20010031766 Prostaglandin receptor ligands
10/18/2001	US20010031757 Administering compounds such as 3-(2-phenylethylamino)-6-methyl-1-(2-amino-6-methyl-5-methylene -carboxamidomethylpyridi nyl)-2-pyrazinone, N'-((1-(Aminoiminomethyl)4-piperidinyl) methyl)-N-(3,3- diphenylpropionyl)-L-proline amide
10/18/2001	US20010031750 Administering an analgesic of an inhibitor of cyclic guanosine monophosphate dependent protein kinase such as rp-8-((4-chlorophenyl)thio)-guanosine 3',5'-cyclic monophosphothioate triethylamine
10/18/2001	US20010031746 Nervous system disorders; psychological disorders
10/18/2001	US20010031730 Method for treatment of glutamate related disorders
10/18/2001	US20010031474 Chimeric neuropeptide Y receptors
10/18/2001	US20010031282 Dissolving solid in dimethyl ether under pressure; precipitation; separation
10/18/2001	US20010031260 Administering tumor necrosis factor antagonist; rheumatic diseases, skin disorders
10/18/2001	US20010029959 Nicotine salts having improved taste, process for their preparation and their use
10/18/2001	DE10108042A1 Crystalline citalopram base and salts with high purity useful for treatment of depression
10/18/2001	DE10019167A1 New 8 beta-substituted 11 beta-(pentyl or hexyl)-estra-1,3,5(10)-triene derivatives, are ovary-selective estrogen receptor ligands useful e.g. as female or male contraceptives or for treating ovarian carcinoma
10/18/2001	DE10013782A1 4-Fluoralkyl-2H-benzopyrane mit antiestrogener Wirksamkeit, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, die diese enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln 4-fluoroalkyl-2H-benzopyrans with antiestrogenic action, processes for their preparation, pharmaceutical compositions containing them and their use for the preparation of medicaments
10/18/2001	DE10007234A1 Peptid und dafür kodierende Nukleinsäure zur Bestimmung, Diagnostik und Therapie von Erkrankungen des Nervensystems Peptide and nucleic acid coding for determining diagnosis and treatment of diseases of the nervous system
10/18/2001	CA2659656A1 The use of vegf165 to treat neuron disorders
10/18/2001	CA2654413A1 Use of vegf and homologues to treat neuron disorders
10/18/2001	CA2405912A1 Albumin fusion proteins
10/18/2001	CA2405800A1 Novel secreted protein
10/18/2001	CA2405568A1 Prion-binding peptidic ligands and methods of using same
10/18/2001	CA2405419A1 Apomorphine derivatives and methods for their use
10/18/2001	CA2405411A1 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases
10/18/2001	CA2405311A1 Multiprotein-complexes comprising a nmda receptor and uses thereof
10/18/2001	CA2405181A1 Human pyruvate dehydrogenese phosphatase
10/18/2001	CA2405163A1 Soluble beta amyloid precursor protein secretion promoters
10/18/2001	CA2405142A1 A pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
10/18/2001	CA2405104A1 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/18/2001	CA2405089A1 Benzoamide piperidine containing compounds and related compounds
10/18/2001	CA2405083A1 New bromodomain protein

1 ... 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 ... 1833